Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Nov;55(11):913–920. doi: 10.1136/thorax.55.11.913

Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review

M Tasche 1, J Uijen 1, R Bernsen 1, J C de Jongste 1, J C van der Wouden 1
PMCID: PMC1745638  PMID: 11050259

Abstract

BACKGROUND—Disodium cromoglycate (DSCG) is included in the BTS guidelines on the treatment of asthma for use in children, but is now used only infrequently. We have identified and interpreted the findings of all published randomised, placebo controlled trials of DSCG in the prophylactic treatment of children with asthma.
METHODS—Several databases were searched to identify trials. Studies were included if they investigated subjects with asthma aged 0-18 years old, addressed maintenance treatment with inhaled DSCG, and were published in English. The methodological quality of the studies was assessed independently by three reviewers. The 95% confidence intervals (CI) of differences in the treatment effect for cough and wheeze between placebo and treatment with DSCG were computed. The estimates were pooled and tested for homogeneity and, to assess possible publication bias, a funnel plot was made and tested for symmetry.
RESULTS—Of the 24 randomised, placebo controlled trials identified, the methodological scores varied widely. The null hypothesis of homogeneity was rejected. Under the assumption of heterogeneity the overall CI for wheeze was 0.11 to 0.26 and for cough was 0.13to 0.27. The overall tolerance intervals (-0.11 to 0.48 and -0.04 to 0.43 for wheeze and cough, respectively) both included zero, so it cannot be concluded that future studies will show an effect of DSCG compared with placebo. Older studies were more often in favour of DSCG. The funnel plots suggest publication bias; small studies with negative or equal outcomes are lacking.
CONCLUSION—Given the apparent publication bias, the small overall treatment effect, and the tolerance interval including zero, there is insufficient evidence that DSCG has a beneficial effect as maintenance treatment in children with asthma.



Full Text

The Full Text of this article is available as a PDF (159.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad S. Cromolyn sodium and anaphylaxis. Ann Intern Med. 1983 Dec;99(6):882–882. doi: 10.7326/0003-4819-99-6-882_2. [DOI] [PubMed] [Google Scholar]
  2. Asthma: a follow up statement from an international paediatric asthma consensus group. Arch Dis Child. 1992 Feb;67(2):240–248. doi: 10.1136/adc.67.2.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernsen R. M., Tasche M. J., Nagelkerke N. J. Variation in baseline risk as an explanation of heterogeneity in meta-analysis by S. D. Walter, Statistics in Medicine, 16, 2883-2900 (1997) Stat Med. 1999 Jan 30;18(2):233–238. doi: 10.1002/(sici)1097-0258(19990130)18:2<233::aid-sim69>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Bertelsen A., Andersen J. B., Busch P., Daugbjerg P., Friis B., Hansen L., Jacobsen S. V., Pelck I., Petersen W., Prahl P. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. A multicentre double-blind placebo controlled study. Allergy. 1986 May;41(4):266–270. doi: 10.1111/j.1398-9995.1986.tb02027.x. [DOI] [PubMed] [Google Scholar]
  5. Calpin C., Macarthur C., Stephens D., Feldman W., Parkin P. C. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature. J Allergy Clin Immunol. 1997 Oct;100(4):452–457. doi: 10.1016/s0091-6749(97)70134-9. [DOI] [PubMed] [Google Scholar]
  6. Chalmers T. C., Smith H., Jr, Blackburn B., Silverman B., Schroeder B., Reitman D., Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981 May;2(1):31–49. doi: 10.1016/0197-2456(81)90056-8. [DOI] [PubMed] [Google Scholar]
  7. Cogswell J. J., Simpkiss M. J. Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch Dis Child. 1985 Aug;60(8):736–738. doi: 10.1136/adc.60.8.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Collins-Williams C., Chiu A. W., Lamenza C., Lewis-McKinley C. A., Williams H., Levison H. Treatment of bronchial asthma with disodium cromoglycate (Intal) in children. Ann Allergy. 1971 Dec;29(12):613–620. [PubMed] [Google Scholar]
  9. Crisp J., Ostrander C., Giannini A., Stroup G., Deamer W. C. Cromolyn sodium therapy for chronic perennial asthma. A double-blind study of 40 children. JAMA. 1974 Aug 12;229(7):787–789. [PubMed] [Google Scholar]
  10. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  11. Dickersin K., Chan S., Chalmers T. C., Sacks H. S., Smith H., Jr Publication bias and clinical trials. Control Clin Trials. 1987 Dec;8(4):343–353. doi: 10.1016/0197-2456(87)90155-3. [DOI] [PubMed] [Google Scholar]
  12. Edmunds A. T., Carswell F., Robinson P., Hughes A. O. Controlled trial of cromoglycate and slow-release aminophylline in perennial childhood asthma. Br Med J. 1980 Sep 27;281(6244):842–842. doi: 10.1136/bmj.281.6244.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Edwards A. M. Sodium cromoglycate (Intal) as an anti-inflammatory agent for the treatment of chronic asthma. Clin Exp Allergy. 1994 Jul;24(7):612–623. doi: 10.1111/j.1365-2222.1994.tb00964.x. [DOI] [PubMed] [Google Scholar]
  14. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Egger M., Smith G. D. Misleading meta-analysis. BMJ. 1995 Mar 25;310(6982):752–754. doi: 10.1136/bmj.310.6982.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fox Z. R., Brickman H. F., Beaudry P. H., Liddell F. D., Eisen A. H. Response to disodium cromoglycate in children with chronic asthma. Can Med Assoc J. 1972 May 6;106(9):975–979. [PMC free article] [PubMed] [Google Scholar]
  17. Furfaro S., Spier S., Drblik S. P., Turgeon J. P., Robert M. Efficacy of cromoglycate in persistently wheezing infants. Arch Dis Child. 1994 Oct;71(4):331–334. doi: 10.1136/adc.71.4.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Geller-Bernstein C., Levin S. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration. 1982;43(4):294–298. doi: 10.1159/000194497. [DOI] [PubMed] [Google Scholar]
  19. Glass J., Archer L. N., Adams W., Simpson H. Nebulised cromoglycate, theophylline, and placebo in preschool asthmatic children. Arch Dis Child. 1981 Aug;56(8):648–651. doi: 10.1136/adc.56.8.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Henry R. L., Hiller E. J., Milner A. D., Hodges I. G., Stokes G. M. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child. 1984 Jan;59(1):54–57. doi: 10.1136/adc.59.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hiller E. J., Milner A. D. Betamethasone 17 valerate aerosol and disodium chromoglycate in severe childhood asthma. Br J Dis Chest. 1975 Apr;69(2):103–106. doi: 10.1016/s0007-0971(75)80026-x. [DOI] [PubMed] [Google Scholar]
  22. Hiller E. J., Milner A. D., Lenney W. Nebulized sodium cromoglycate in young asthmatic children. Double-blind trial. Arch Dis Child. 1977 Nov;52(11):875–876. doi: 10.1136/adc.52.11.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hoag J. E., McFadden E. R., Jr Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Ann Allergy. 1991 Jan;66(1):53–63. [PubMed] [Google Scholar]
  24. Holgate S. T. Inhaled sodium cromoglycate. Respir Med. 1996 Aug;90(7):387–390. doi: 10.1016/s0954-6111(96)90110-9. [DOI] [PubMed] [Google Scholar]
  25. Hyde J. S., Buranakul B., Vithayasai V. Effect of cromolyn sodium on childhood asthma. Ann Allergy. 1970 Oct;28(10):449–458. [PubMed] [Google Scholar]
  26. Hyde J. S., Isenberg P. D., Floro L. D. Short- and long-term prophylaxis with cromolyn sodium in chronic asthma. Chest. 1973 Jun;63(6):875–880. doi: 10.1378/chest.63.6.875. [DOI] [PubMed] [Google Scholar]
  27. Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J., Gavaghan D. J., McQuay H. J. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996 Feb;17(1):1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
  28. Lester M. R., Bratton D. L. Adverse reactions to cromolyn sodium: patient report and review of the literature. Clin Pediatr (Phila) 1997 Dec;36(12):707–710. doi: 10.1177/000992289703601207. [DOI] [PubMed] [Google Scholar]
  29. Limburg M. Treatment of children in an asthma centre with disodium cromoqlycate. Double-blind crossover trial. Acta Allergol. 1971 Oct;26(5):367–382. [PubMed] [Google Scholar]
  30. Marks M. B. Therapeutic efficacy of cromolyn in childhood asthma. Am J Dis Child. 1974 Sep;128(3):301–304. doi: 10.1001/archpedi.1974.02110280031004. [DOI] [PubMed] [Google Scholar]
  31. Martinez F. D., Wright A. L., Taussig L. M., Holberg C. J., Halonen M., Morgan W. J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995 Jan 19;332(3):133–138. doi: 10.1056/NEJM199501193320301. [DOI] [PubMed] [Google Scholar]
  32. Matthew D. J. The use of nebulised sodium cromoglycate in children. Acta Allergol. 1977;Suppl 13:34–43. [PubMed] [Google Scholar]
  33. Michael R. Evaluation of disodium cromoglycate in asthmatic children. Ann Allergy. 1970 Jul;28(7):299–306. [PubMed] [Google Scholar]
  34. Moher D., Jadad A. R., Nichol G., Penman M., Tugwell P., Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials. 1995 Feb;16(1):62–73. doi: 10.1016/0197-2456(94)00031-w. [DOI] [PubMed] [Google Scholar]
  35. Mulrow C. D. Rationale for systematic reviews. BMJ. 1994 Sep 3;309(6954):597–599. doi: 10.1136/bmj.309.6954.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Paterson N. A., Peat J. K., Mellis C. M., Xuan W., Woolcock A. J. Accuracy of asthma treatment in schoolchildren in NSW, Australia. Eur Respir J. 1997 Mar;10(3):658–664. [PubMed] [Google Scholar]
  37. Price J. F., Weller P. H. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). Respir Med. 1995 May;89(5):363–368. doi: 10.1016/0954-6111(95)90009-8. [DOI] [PubMed] [Google Scholar]
  38. Robins A. W., Lloyd B. W. Most consultants deviate from asthma guidelines. BMJ. 1995 Aug 19;311(7003):508–508. doi: 10.1136/bmj.311.7003.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schweitzer M., Balano K. B. Cromolyn use in young children. Ann Pharmacother. 1994 Jul-Aug;28(7-8):886–888. [PubMed] [Google Scholar]
  40. Sheffer A. L., Rocklin R. E., Goetzl E. J. Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med. 1975 Dec 11;293(24):1220–1224. doi: 10.1056/NEJM197512112932402. [DOI] [PubMed] [Google Scholar]
  41. Shioda H., Murano J., Mishima K., Iikura Y., Tanaka F., Izeki M. Disodium cromoglycate (intal) in the treatment of bronchial asthma in children. Acta Allergol. 1970 Jun;25(2):221–235. doi: 10.1111/j.1398-9995.1970.tb01393.x. [DOI] [PubMed] [Google Scholar]
  42. Silverman M., Connolly N. M., Balfour-Lynn L., Godfrey S. Long-term trial of disodium cromoglycate and isoprenaline in children with asthma. Br Med J. 1972 Aug 12;3(5823):378–381. doi: 10.1136/bmj.3.5823.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sly R. M. New guidelines for diagnosis and management of asthma. Ann Allergy Asthma Immunol. 1997 May;78(5):427–437. doi: 10.1016/S1081-1206(10)63229-2. [DOI] [PubMed] [Google Scholar]
  44. Smith J. M., Devey G. F. Clinical trial of disodium cromoglycate in treatment of asthma in children. Br Med J. 1968 May 11;2(5601):340–344. doi: 10.1136/bmj.2.5601.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tasche M. J., van der Wouden J. C., Uijen J. H., Ponsioen B. P., Bernsen R. M., van Suijlekom-Smit L. W., de Jongste J. C. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. Lancet. 1997 Oct 11;350(9084):1060–1064. doi: 10.1016/s0140-6736(97)05333-6. [DOI] [PubMed] [Google Scholar]
  46. Van Bever H. P., Schuddinck L., Wojciechowski M., Stevens W. J. Aerosolized budesonide in asthmatic infants: a double blind study. Pediatr Pulmonol. 1990;9(3):177–180. doi: 10.1002/ppul.1950090310. [DOI] [PubMed] [Google Scholar]
  47. Warner J. O. Review of prescribed treatment for children with asthma in 1990. BMJ. 1995 Sep 9;311(7006):663–666. doi: 10.1136/bmj.311.7006.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Warner J. O. The place of Intal in paediatric practice. Respir Med. 1989 May;83 (Suppl A):33–37. doi: 10.1016/s0954-6111(89)80248-3. [DOI] [PubMed] [Google Scholar]
  49. Yuksel B., Greenough A. Inhaled sodium cromoglycate for pre-term children with respiratory symptoms at follow-up. Respir Med. 1992 Mar;86(2):131–134. doi: 10.1016/s0954-6111(06)80229-5. [DOI] [PubMed] [Google Scholar]
  50. van Essen-Zandvliet E. E., Hughes M. D., Waalkens H. J., Duiverman E. J., Pocock S. J., Kerrebijn K. F. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis. 1992 Sep;146(3):547–554. doi: 10.1164/ajrccm/146.3.547. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES